Clinical Trial Update: TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for TWB-103 in adults with donor site wounds from split-thickness skin grafts; study completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Donor-site Complication
• Split-thickness Skin Graft Donor Site Complications

Drugs mentioned

• TWB-103

Snippet

Sponsor: Transwell Biotech Co., Ltd. | Conditions: Donor Site Complication | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-07-28